Glucose-dependent Insulinotropic Peptide (22-51) (human) (trifluoroacetate salt)
- CAS No.
- Chemical Name:
- Glucose-dependent Insulinotropic Peptide (22-51) (human) (trifluoroacetate salt)
- Synonyms
- Glucose-dependent Insulinotropic Peptide (22-51) (human) (trifluoroacetate salt)
- CBNumber:
- CB915513947
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MOL File:
- Mol file
Glucose-dependent Insulinotropic Peptide (22-51) (human) (trifluoroacetate salt) price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 36968 | Glucose-dependent Insulinotropic Peptide (22-51) (human) (trifluoroacetate salt) ≥98% | 1mg | $29 | 2026-04-30 | Buy | |
| Cayman Chemical | 36968 | Glucose-dependent Insulinotropic Peptide (22-51) (human) (trifluoroacetate salt) ≥98% | 5mg | $135 | 2026-04-30 | Buy | |
| Cayman Chemical | 36968 | Glucose-dependent Insulinotropic Peptide (22-51) (human) (trifluoroacetate salt) ≥98% | 10mg | $253 | 2026-04-30 | Buy | |
| Cayman Chemical | 36968 | Glucose-dependent Insulinotropic Peptide (22-51) (human) (trifluoroacetate salt) ≥98% | 25mg | $597 | 2026-04-30 | Buy |
Glucose-dependent Insulinotropic Peptide (22-51) (human) (trifluoroacetate salt) Chemical Properties, Uses, Production
Description
Glucose-dependent insulinotropic peptide (GIP) (22-51) is a pro-atherogenic 30-amino acid peptide corresponding to residues 22-51 of the GIP precursor protein proGIP that has been found in human plasma.1 It induces IκB-α degradation and NF-κB nuclear translocation in macrophage-differentiated THP-1 cells and isolated human aortic endothelial cells when used at a concentration of 1 µM. In vivo, GIP (22-51) increases atherosclerotic lesion area and plaque formation in ApoE-/- mice.WARNING This product is not for human or veterinary use.
References
[1] TSUGUTO MASAKI. GIP_HUMAN[22-51] is a new proatherogenic peptide identified by native plasma peptidomics.[J]. ACS Applied Electronic Materials, 2021: 14470. DOI: 10.1038/s41598-021-93862-w
Glucose-dependent Insulinotropic Peptide (22-51) (human) (trifluoroacetate salt) Preparation Products And Raw materials
Raw materials
Preparation Products
Glucose-dependent Insulinotropic Peptide (22-51) (human) (trifluoroacetate salt) Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Cayman Chemical Company | -- | sales@caymanchem.com | China | 6808 | 58 |
| Neobioscience Co., Ltd. | -- | info@neobioscience.com | CHINA | 6192 | 58 |
| Supplier | Advantage |
|---|---|
| Cayman Chemical Company | 58 |
| Neobioscience Co., Ltd. | 58 |
